Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist

Compiled from ClinicalTrials.gov and CTIS registry records · Last verified 26 Sep 2026 · Editorial standards

At a glance

Power Life Sciences is the lead sponsor of 42 current clinical trials in our USA register. None of its ClinicalTrials.gov trials is recruiting at the moment. All registered phases are Observational. The most-studied condition is Prostate Cancer.

ClinicalTrials.gov trials by status

Not yet open42100%

Trials by phase

Observational42100%

Clinical trials sponsored by Power Life Sciences

42 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
Analyzing Clinical Trial Experiences of Prostate Cancer Patients NCT05411354 · Prostate Cancer	Observational	Not yet open	2024-09	USA
Revealing Engagement Patterns Among Endometrial Cancer Patients NCT05998798 · Endometrial Cancer	Observational	Not yet open	2024-09	USA
A Detailed Look At What Patients Experience In Medullary Thyroid Cancer Clinical Study NCT06079723 · Medullary Thyroid Cancer	Observational	Not yet open	2024-11	USA
Examining Engagement Trends Among Participants in Peripheral Neuropathy Clinical Research NCT06338384 · Peripheral Neuropathy	Observational	Not yet open	2025-04	USA
Studying Patterns in Patient Engagement Among Treatment Resistant Depression Patients NCT06101914 · Treatment Resistant Depression	Observational	Not yet open	2024-11	USA
Navigating the Clinical Research Process for Lymphoma NCT06070246 · Lymphoma	Observational	Not yet open	2024-10	USA
Investigating Participation Patterns of Patients in Atopic Dermatitis Clinical Trials NCT06174493 · ClinicalTrials.gov ↗ · Atopic Dermatitis	Observational	Not yet open	2025-01	USA
A Journey Into Participation Patterns Among Patients With Hidradenitis Suppurativa NCT06201858 · ClinicalTrials.gov ↗ · Hidradenitis Suppurativa	Observational	Not yet open	2025-01	USA
Understanding Participation Habits Among Plaque Psoriasis Patients NCT06338358 · ClinicalTrials.gov ↗ · Plaque Psoriasis	Observational	Not yet open	2025-04	USA
Assessing Patient Engagement in Keratoconus Clinical Research NCT06288737 · ClinicalTrials.gov ↗ · Keratoconus	Observational	Not yet open	2025-03	USA
Studying Patterns in Patient Engagement Among Tardive Dyskinesia Patients NCT06218719 · ClinicalTrials.gov ↗ · Tardive Dyskinesia	Observational	Not yet open	2025-02	USA
Understanding Patient Engagement Trends in Anxiety Disorder Clinical Research NCT06155565 · ClinicalTrials.gov ↗ · Anxiety Disorder	Observational	Not yet open	2024-12	USA
A Journey Into Participation Patterns Among Metastatic Prostate Cancer Patients NCT06009549 · ClinicalTrials.gov ↗ · Metastatic Prostate Cancer	Observational	Not yet open	2024-09	USA
Understanding Engagement Trends in Chondrosarcoma Clinical Trials NCT06029478 · ClinicalTrials.gov ↗ · Chondrosarcoma	Observational	Not yet open	2024-10	USA
Exploring Acne Treatments Through Clinical Research Participation NCT07010458 · ClinicalTrials.gov ↗ · Acne	Observational	Not yet open	2026-06	USA
Exploring Engagement Dynamics Among Individuals Impacted by Bladder Cancer NCT06009510 · ClinicalTrials.gov ↗ · Bladder Cancer	Observational	Not yet open	2024-09	USA
Revealing Engagement Patterns Among Hepatic Encephalopathy Patients NCT06201988 · ClinicalTrials.gov ↗ · Hepatic Encephalopathy	Observational	Not yet open	2025-01	USA
An Observational Exploration of Clinical Trials Targeting Traumatic Brain Injury NCT06264518 · ClinicalTrials.gov ↗ · Traumatic Brain Injury	Observational	Not yet open	2025-03	USA
Assessing the Experience of Patients Undergoing Follicular Lymphoma Clinical Research NCT06049485 · ClinicalTrials.gov ↗ · Follicular Lymphoma	Observational	Not yet open	2024-10	USA
Delving Into Borderline Personality Disorder Clinical Trial Experiences NCT05989529 · ClinicalTrials.gov ↗ · Borderline Personality Disorder	Observational	Not yet open	2024-09	USA
Exploring Merkel Cell Carcinoma Clinical Trial Engagement Patterns NCT06039033 · ClinicalTrials.gov ↗ · Merkel Cell Carcinoma	Observational	Not yet open	2024-10	USA
Exploring Clinical Study Experiences of People With Post Traumatic Stress Disorder NCT06146049 · ClinicalTrials.gov ↗ · Post Traumatic Stress Disorder	Observational	Not yet open	2024-12	USA
Investigative Analysis of Soft Tissue Sarcoma Clinical Trials: An Observational Study NCT06264505 · ClinicalTrials.gov ↗ · Soft Tissue Sarcoma	Observational	Not yet open	2025-03	USA
Understanding Patient Engagement Trends in TBI Clinical Research NCT06288698 · ClinicalTrials.gov ↗ · TBI	Observational	Not yet open	2025-03	USA
Patient Perspectives in Mantle Cell Lymphoma Clinical Research NCT06049472 · ClinicalTrials.gov ↗ · Mantle Cell Lymphoma	Observational	Not yet open	2024-10	USA
Revealing Engagement Dynamics Among Diabetic Kidney Disease Patients NCT06101901 · ClinicalTrials.gov ↗ · Diabetic Kidney Disease	Observational	Not yet open	2024-11	USA
Investigating Participation Patterns Among Recurrent Ovarian Cancer Patients NCT06070285 · ClinicalTrials.gov ↗ · Recurrent Ovarian Cancer	Observational	Not yet open	2024-10	USA
Investigating Engagement Patterns and Participation Trends Among Liposarcoma Patients NCT06039046 · ClinicalTrials.gov ↗ · Liposarcoma	Observational	Not yet open	2024-10	USA
Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials NCT06029465 · ClinicalTrials.gov ↗ · Rhabdomyosarcoma	Observational	Not yet open	2024-10	USA
Evaluating the Occurrence of Participation Trends Among Weight Loss Clinical Trials Patients NCT06155552 · ClinicalTrials.gov ↗ · Weight Loss	Observational	Not yet open	2024-12	USA
Revealing Engagement Dynamics Among Semantic Dementia Patients NCT06218732 · ClinicalTrials.gov ↗ · Semantic Dementia	Observational	Not yet open	2025-02	USA
Delving Into Participation Patterns in Social Anxiety Studies NCT06020170 · ClinicalTrials.gov ↗ · Social Anxiety	Observational	Not yet open	2024-09	USA
Understanding of Participation Trends Within Generalized Anxiety Disorder Patients Involved in Clinical Trials NCT06254157 · ClinicalTrials.gov ↗ · Generalized Anxiety Disorder	Observational	Not yet open	2025-03	USA
Navigating the Clinical Research Process for Mild Cognitive Impairment NCT06207903 · ClinicalTrials.gov ↗ · Mild Cognitive Impairment	Observational	Not yet open	2025-02	USA
Insights Into Participating in Studies for Bone Cancer NCT06070259 · ClinicalTrials.gov ↗ · Bone Cancer	Observational	Not yet open	2024-10	USA
Delving Into Participation Trends in Renal Cell Carcinoma Studies NCT06093568 · ClinicalTrials.gov ↗ · Renal Cell Carcinoma	Observational	Not yet open	2024-11	USA
Delving Into Participation Trends of Scleroderma Clinical Trials NCT06264492 · ClinicalTrials.gov ↗ · Scleroderma	Observational	Not yet open	2025-03	USA
Investigating Participation Patterns Among Stage IV Melanoma Patients NCT06093594 · ClinicalTrials.gov ↗ · Stage IV Melanoma	Observational	Not yet open	2024-11	USA
Insights Into Participating in Clinical Studies for Anorexia NCT06146075 · ClinicalTrials.gov ↗ · Anorexia	Observational	Not yet open	2024-12	USA
Exploring Clinical Study Experiences of People With Anorexia Nervosa NCT06207890 · ClinicalTrials.gov ↗ · Anorexia Nervosa	Observational	Not yet open	2025-02	USA
Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients NCT06070272 · ClinicalTrials.gov ↗ · Recurrent Prostate Cancer	Observational	Not yet open	2024-10	USA
Insights Into Participating in Studies for Uterine Cancer NCT05998811 · ClinicalTrials.gov ↗ · Uterine Cancer	Observational	Not yet open	2024-09	USA

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Conditions in Power Life Sciences trials

42 conditions

Prostate Cancer1 Endometrial Cancer1Medullary Thyroid Cancer1Peripheral Neuropathy1Treatment Resistant Depression1Lymphoma1 Atopic Dermatitis1 Hidradenitis Suppurativa1 Plaque Psoriasis1Keratoconus1Tardive Dyskinesia1Anxiety Disorder1Metastatic Prostate Cancer1Chondrosarcoma1Acne1Bladder Cancer1Hepatic Encephalopathy1Traumatic Brain Injury1 Follicular Lymphoma1Borderline Personality Disorder1Merkel Cell Carcinoma1Post Traumatic Stress Disorder1Soft Tissue Sarcoma1TBI1

By trial register

Register	Trials	Recruiting
Clinical trials in USA	42	0

A trial with sites in more than one country appears in each of those registers.

Other sponsors in Prostate Cancer

Sponsor	Trials
Peking University First Hospital	12
Jiangsu HengRui Medicine	6
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	6
Astellas Pharma Global Development	4
Lantheus Medical Imaging	3
Janux Therapeutics	3
First Affiliated Hospital of Fujian Medical University	3
Anhui Provincial Hospital	3
Candel Therapeutics	2
Clarity Pharmaceuticals	2

Sponsors with the most current trials registered for this condition.

Questions about Power Life Sciences trials

How many clinical trials does Power Life Sciences sponsor?

Power Life Sciences is the lead sponsor of 42 current trials on ClinicalTrials.gov in our USA register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Power Life Sciences trials recruiting?

Not at the moment. None of its 42 ClinicalTrials.gov trials is recruiting; they are active but closed to enrolment, not yet open, or enrolling by invitation. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.

Power Life Sciences clinical trials